Prognosis of a Chinese patient with chronic lymphocytic leukemia who acquired a TP53 mutation following treatment with a BTK inhibitor.
Year: 2023
Type: article
Abstract: (L265P) mutation in an Asian patient.
Source: PubMed Central
Authors: Yan-Ling Ding, Jie Li, Jun Yuan, Qiang Wei, Yan Li
Institutions: Hebei North University, Hebei General Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4385715615